4
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Immunosuppressive factors in porcine vitreous body

&
Pages 1141-1149 | Received 09 Sep 1991, Accepted 22 Nov 1991, Published online: 02 Jul 2009
 

Abstract

High molecular (designated Sv,>3K) and low molecular (designated Sv, c3K) fractions were prepared by filtration of porcine vitreous extracts through a membrane filter with a molecular weight cut-off of 3,000 daltons. Both fractions inhibited mitogen-stimulated proliferation of lymphocytes from rat spleen, as determined by [3H]-thymidine incorporation. The inhibitory activity of Sv,>3K was markedly enhanced by acid treatment and abolished almost completely by incubation with anti-tiansfonning growth factor beta (TGF-β) antibody. The major immunosuppressive factor in Sv,>3K was therefore concluded to be TGF-β On the other hand, the inhibitory activity of Sv, < 3K was not affected by acid treatment or by incubation with anti-TGF-p antibody but was decreased by proteolytic treatment. From these results the immunosuppressive factor in Sv, < 3K was attributed to a low molecular substance which is probably a peptide structually unrelated to TGF-β. The inhibitory effects of both Sv, > 3K and Sv, < 3K were reversible and therefore not cytotoxic. Both factors seemed to suppress lymphoproliferation without affecting the expression of Interleukin-2 receptor, CD4 and CD8 on the cell surface of cultured lymphocytes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.